The epilepsy monitoring devices market exhibits diversity with wearable, smart, and conventional devices catering to varied needs. Focused on both focal and generalized seizures, the market incorporates advanced technologies. Wearable and smart devices offer real-time monitoring and data collection, enhancing patient care and management. Conventional devices maintain their relevance in traditional diagnostic settings. The market's technological spectrum underscores its adaptability to evolving healthcare requirements, addressing a wide range of epilepsy types for comprehensive monitoring and improved treatment strategies.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-epilepsy-monitoring-devices-market
Data Bridge Market Research analyses that the Global Epilepsy Monitoring Devices Market value, which was USD 976.81 million in 2022, is expected to reach the value of USD 1,510.51 million by 2030, at a CAGR of 5.6% during the forecast period of 2023-2030. Rising awareness regarding epilepsy and its management is a significant driver for the epilepsy monitoring devices market. This increased understanding prompts greater adoption of monitoring devices, contributing to market expansion as individuals seek effective solutions for managing and monitoring epileptic conditions.
Key Findings of the Study
Aging population is expected to drive the market's growth rate
The aging population is a pivotal driver for the epilepsy monitoring devices market. As the demographic of elderly individuals grows, so does the prevalence of neurological disorders such as epilepsy. This heightened susceptibility propels the demand for monitoring devices, creating a significant market driver. The need to manage and monitor epilepsy in the elderly population drives innovation and adoption of advanced monitoring technologies, fostering the overall growth of the market.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Wearable Devices, Smart Devices, and Conventional Devices), Type (Focal Seizures, and Generalized Seizures), Patient Type (Paediatric, Geriatric, and Adults), End User (Hospitals, Homecare Setting, Neurology Centres, Diagnostic Centres, Ambulatory Surgical Centres and Clinics, and Others), Distribution Channel (Retail Sales, Online Sales, Direct Tenders, and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
NIHON KOHDEN CORPORATION (Japan), Masimo (U.S.), Apple Inc. (U.S.), Natus Medical Incorporated (U.S.), Owlet (U.S.), Neurotech, LLC (U.S.), SmartMonitor (U.S.), Epilert (U.S.),
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The global epilepsy monitoring devices market is segmented into five notable segments based on product type, type, patient type, end user and distribution channel
- On the basis of product type, the global epilepsy monitoring devices market is segmented into wearable devices, smart devices and conventional devices
- On the basis of type, the global epilepsy monitoring devices market is segmented into focal seizures and generalized seizures
- On the basis of patient type, the global epilepsy monitoring devices market is segmented into pediatric, geriatric and adults
- On the basis of end user, the global epilepsy monitoring devices market is segmented into hospitals, homecare settings, neurology centres, diagnostic centres, ambulatory surgical centres and clinics and others
- On the basis of distribution channel, the global epilepsy monitoring devices market is segmented into retail sales, online sales, direct tenders and others
Major Players
Data Bridge Market Research recognizes the following companies as the global epilepsy monitoring devices market players in global epilepsy monitoring devices market are NIHON KOHDEN CORPORATION (Japan), Masimo (U.S.), Apple Inc. (U.S.), Natus Medical Incorporated (U.S.).
Market Developments
- In December 2022, NIHON KOHDEN CORPORATION's expansion through a new sales branch, Nihon Kohden Singapore (NKS), in the Philippines, reflects a strategic move to facilitate the seamless registration of medical devices. This initiative aligns with the company's goal to enhance market presence and boost sales, indicating a proactive approach in addressing the growing demand for epilepsy monitoring devices in the Philippines
- In May 2022, Spanish start-up mjn-NEURO launched mjn-SERAS, a groundbreaking device for seizure detection in the U.K. Leveraging artificial intelligence, it offers up to 3 minutes of advanced warning, significantly improving epilepsy monitoring. This innovation showcases the continuous evolution of the epilepsy monitoring devices market towards more effective and proactive solutions
- In February 2022, Epitel secured USD 12.5 million in Series A funding for its wearable electroencephalogram (EEG) system designed for seizure detection. This funding injection underscores the growing interest and support for innovative solutions within the epilepsy monitoring devices market, highlighting a positive trend toward advancements in seizure detection technology
- In February 2022, Masimo initiated a merger to acquire Viper Holdings Corporation, owner of Sound United, a consumer technology firm with premium brands. This potentially influencing its revenue and market position in the broader healthcare technology landscape
Regional Analysis
Geographically, the countries covered in the global epilepsy monitoring devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in the global epilepsy monitoring devices market during the forecast period 2023-2030
The North America dominates the global epilepsy monitoring devices market in the forecasted period, driven by an increase in market players and the availability of advanced devices. The market is further boosted by a rising number of government and private collaborations. These factors collectively contribute to the expansion of the market, meeting the growing demand for innovative epilepsy monitoring solutions in the region.
For more detailed information about the global epilepsy monitoring devices market report, click here – https://www.databridgemarketresearch.com/reports/global-epilepsy-monitoring-devices-market
